MDR 2017 Made Simple: Chapter V – Import Essentials for Medical Devices in India

 MDR 2017 Made Simple: Chapter V – Import Essentials (Part 5 of 12)

By Ankur K. Khare – Biomedical Engineer | AI Ethics & Medical Innovation

Welcome to Part 5 of our MDR 2017 deep-dive series. After manufacturing comes the other end of the supply chain: importing medical devices into India. Chapter V lays out the rules for overseas manufacturers and their Indian agents to bring Class A–D devices into the country.

Why Import Rules Matter

A flawless import process ensures:

·         Smooth market entry without customs delays

·         Regulatory compliance to avoid product seizures

·         Right documentation to satisfy CLA scrutiny

·         Efficient approvals saving months of waiting

Missteps can lead to lost shipments, fines, or forced product re-export.

Key Players in the Import Process

1.       Foreign Manufacturer

o    Must hold a valid manufacturing license in its home country

o    Provides a Free Sale Certificate (FSC) from a regulated market

2.      Indian Authorized Agent

o    Holds a valid wholesale or manufacturing license (MD-14)

o    Submits import applications and interacts with CDSCO

o    Acts as liaison for adverse-event reporting

3.      Central Licensing Authority (CLA)

o    Reviews import applications (Form MD-15)

o    Verifies FSC, quality standards, and device master file

o    Issues import license or raises queries

Step-by-Step Import License Process

Step 1: Appoint an Indian Agent

·         Sign Power of Attorney granting rights to apply on manufacturer’s behalf

·         Ensure agent holds valid Form MD-14 license

Step 2: Gather Required Documents

·         Form MD-14: Wholesale/manufacturing license copy

·         Free Sale Certificate (FSC): From a country with equivalent regulatory standards (US, EU, Japan, Australia)

·         Device Master File: Technical dossier, risk assessment, clinical data

·         Quality Management System Certificate: ISO 13485 or equivalent

·         Labeling Samples: As per Chapter VI rules

·         Declaration of Conformity: From manufacturer

Step 3: Submit Form MD-15 Application

·         Online via CDSCO SUGAM portal

·         Attach scanned copies of all documents

·         Pay fees:

o    Class A: ₹1,000/site

o    Class B: ₹2,000/site

o    Class C/D: ₹3,000/site

Step 4: CDSCO Scrutiny

·         CLA reviews within 45 days

·         Queries (if any) must be answered within 30 days

·         May request additional data or arrange document-only audit

Step 5: Import License Grant

·         CLA issues MD-15 license valid for 5 years

·         Agent can import specified device models and quantities

·         License number must appear on all shipments

Country-Specific Considerations

Exporting Country	Requirement
US/EU/Canada/Australia	FSC + ISO 13485 certificate
Japan/South Korea	FSC + clinical trial waiver may apply
Other Countries	FSC + local clinical investigation required

 Devices from non-regulated countries often require local clinical data for Class C/D.

Real-World Import Case Studies

Case Study 1: Class B Contact Lens from the EU

·         Action: Agent submitted MD-15 with EU FSC and ISO 13485 certificate

·         Timeline: License granted in 30 days

·         Lesson: FSC from a well-recognized authority expedites review

Case Study 2: Class D Heart Valve from the US

·         Action: Detailed clinical data and post-market surveillance reports provided

·         Challenge: CLA requested a device demonstration audit in India

·         Result: Audit conducted in 60 days; license granted in 90 days total

·         Tip: Be prepared for surprise audits on high-risk devices

Case Study 3: Class C Diagnostic Kit from a Non-Regulated Country

·         Action: Agent provided FSC and local clinical trial plan

·         Outcome: Clinical study approval (MD-22/23) required before granting import license

·         Key Point: Non-regulated origins trigger extra clinical investigation steps

Common Pitfalls & How to Avoid Them

·         Expired FSC: Ensure validity covers application period

·         Incomplete Dossier: Always include complete device master file

·         Wrong Fee Payment: Match fee to correct class and number of sites

·         Labeling Non-compliance: Stick to Chapter VI labeling rules

·         Ignoring Local Trials: Plan ahead for non-regulated-country devices

Exam-Ready Quick Reference

·         Forms:

o    MD-14: Agent license

o    MD-15: Import license

·         Fees: ₹1,000 to ₹3,000 based on device class

·         Timeline: 45 days for normal scrutiny

·         Key Doc: Free Sale Certificate from recognized authority

·         Validity: 5 years per license

Looking Ahead: What’s Next?

In Part 6, we’ll cover Chapter VI: Labeling & Packaging—ensuring your imported or manufactured device meets all naming, instruction, and shelf-life requirements before it reaches patients.

Join the Discussion

Question: Have you faced any challenges obtaining an FSC or local audit?
Poll: Which import step is most challenging?

·         FSC procurement

·         Clinical data submission

·         Surprise audits

·         Label compliance

Share your experiences and tips!

Key Takeaways

✅ Appoint a licensed Indian agent (MD-14)
✅ FSC from a regulated market smooths approvals
✅ Non-regulated origins need local clinical trials
✅ Labeling and dossier completeness are critical

This is Part 5 of our 12-part MDR 2017 series. Next: Chapter VI – Labeling & Packaging Essentials. Stay tuned!